JP2023542879A5 - - Google Patents
Info
- Publication number
- JP2023542879A5 JP2023542879A5 JP2023517259A JP2023517259A JP2023542879A5 JP 2023542879 A5 JP2023542879 A5 JP 2023542879A5 JP 2023517259 A JP2023517259 A JP 2023517259A JP 2023517259 A JP2023517259 A JP 2023517259A JP 2023542879 A5 JP2023542879 A5 JP 2023542879A5
- Authority
- JP
- Japan
- Prior art keywords
- months
- population
- treated
- pharmaceutical product
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063080013P | 2020-09-17 | 2020-09-17 | |
| US63/080,013 | 2020-09-17 | ||
| US202163196641P | 2021-06-03 | 2021-06-03 | |
| US63/196,641 | 2021-06-03 | ||
| US202163240794P | 2021-09-03 | 2021-09-03 | |
| US63/240,794 | 2021-09-03 | ||
| PCT/US2021/050627 WO2022060955A1 (en) | 2020-09-17 | 2021-09-16 | Methods for treating cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542879A JP2023542879A (ja) | 2023-10-12 |
| JP2023542879A5 true JP2023542879A5 (https=) | 2024-09-11 |
Family
ID=80777582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517259A Pending JP2023542879A (ja) | 2020-09-17 | 2021-09-16 | １９１ｐ４ｄ１２タンパク質に結合する抗体薬物複合体（ａｄｃ）を用いたがんの治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230330251A1 (https=) |
| EP (1) | EP4213888A4 (https=) |
| JP (1) | JP2023542879A (https=) |
| KR (1) | KR20230091885A (https=) |
| AU (1) | AU2021344976A1 (https=) |
| CA (1) | CA3194339A1 (https=) |
| IL (1) | IL301163A (https=) |
| MX (1) | MX2023003059A (https=) |
| PH (1) | PH12023550745A1 (https=) |
| TW (1) | TWI911277B (https=) |
| WO (1) | WO2022060955A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019392090A1 (en) | 2018-12-03 | 2021-06-17 | Agensys, Inc. | Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof |
| IL302006A (en) * | 2020-10-11 | 2023-06-01 | Agensys Inc | Methods for treating cancer with antibody-drug conjugates (ADC) that bind to proteins 191P4D12 |
| US20240010701A1 (en) * | 2022-06-01 | 2024-01-11 | ALX Oncology Inc. | Combination therapies for treating urothelial carcinoma |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX347954B (es) * | 2010-09-29 | 2017-05-19 | Agensys Inc | Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12. |
| SG11202001930QA (en) * | 2017-09-07 | 2020-04-29 | Dragonfly Therapeutics Inc | Proteins binding nkg2d, cd16 and a tumor-associated antigen |
| EP3710600B1 (en) * | 2017-11-17 | 2025-03-12 | GMDx Co Pty Ltd | Systems and methods for predicting the efficacy of cancer therapy |
| CN109504660B (zh) * | 2018-11-02 | 2021-08-06 | 温州启星生物技术有限公司 | 一种第四代car-t细胞及其构建方法和应用 |
| AU2019392090A1 (en) * | 2018-12-03 | 2021-06-17 | Agensys, Inc. | Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof |
| KR20220106779A (ko) * | 2019-11-25 | 2022-07-29 | 어젠시스 인코포레이티드 | 191p4d12 단백질에 결합하는 항체 약물 접합체(adc)를 사용한 암의 치료 |
-
2021
- 2021-09-16 KR KR1020237012738A patent/KR20230091885A/ko active Pending
- 2021-09-16 IL IL301163A patent/IL301163A/en unknown
- 2021-09-16 US US18/025,349 patent/US20230330251A1/en active Pending
- 2021-09-16 CA CA3194339A patent/CA3194339A1/en active Pending
- 2021-09-16 EP EP21870200.9A patent/EP4213888A4/en active Pending
- 2021-09-16 AU AU2021344976A patent/AU2021344976A1/en active Pending
- 2021-09-16 TW TW110134601A patent/TWI911277B/zh active
- 2021-09-16 PH PH1/2023/550745A patent/PH12023550745A1/en unknown
- 2021-09-16 WO PCT/US2021/050627 patent/WO2022060955A1/en not_active Ceased
- 2021-09-16 JP JP2023517259A patent/JP2023542879A/ja active Pending
- 2021-09-16 MX MX2023003059A patent/MX2023003059A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI601537B (zh) | 抗－ｃｄ１９類美登醇（ｍａｙｔａｎｓｉｎｏｉｄ）免疫結合物抗體於治療ｂ－細胞惡性症狀之用途 | |
| JP2023542879A5 (https=) | ||
| BR112021008778A2 (pt) | Métodos de tratamento da oftalmopatia de graves usando anticorpos anti-fcrn | |
| US10792370B2 (en) | Antibody-drug conjugate | |
| CN111065411A (zh) | Pd-1抗体和vegfr抑制剂联合治疗小细胞肺癌的用途 | |
| JP7160533B2 (ja) | 多発性骨髄腫（ｍｍ）の処置 | |
| JP2024133544A5 (https=) | ||
| JP2011507932A5 (https=) | ||
| JP2023545432A5 (https=) | ||
| JP2021526534A5 (https=) | ||
| JP2022513684A5 (https=) | ||
| JP2025501978A5 (https=) | ||
| JP2021518394A5 (https=) | ||
| JP2015500822A5 (https=) | ||
| JP2022513386A5 (https=) | ||
| JP2021523233A5 (https=) | ||
| JP2021523158A5 (https=) | ||
| CN105251004A (zh) | 在诊断和治疗类风湿性关节炎中使用的包含抗-cd6单克隆抗体的药物组合物 | |
| JP2024534602A5 (https=) | ||
| WO2023061472A1 (zh) | 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途 | |
| JP2022541591A5 (https=) | ||
| JP2023500888A5 (https=) | ||
| JP2023500697A5 (https=) | ||
| KR20200010472A (ko) | 항-cd19 항체 및 베네토클락스 조합 치료에 대한 치료 패러다임 | |
| EP3896089A1 (en) | Use of il-15 protein complex joint pd-l1 antibody for treating tumor diseases |